These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1311475)

  • 21. Cytomegalovirus infection in transplant patients.
    Betts RF
    Prog Med Virol; 1982; 28():44-64. PubMed ID: 6283602
    [No Abstract]   [Full Text] [Related]  

  • 22. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
    Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L
    Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation.
    Cooper DK; Novitzky D; Schlegel V; Muchmore JS; Cucchiara A; Zuhdi N
    J Heart Lung Transplant; 1991; 10(5 Pt 1):656-62; discussion 662-3. PubMed ID: 1659901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of cytomegalovirus infection after liver transplantation.
    Sampathkumar P; Paya CV
    Liver Transpl; 2000 Mar; 6(2):144-56. PubMed ID: 10719012
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of CMV infections and disease in transplantation.
    Schmidt GM
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):126-9, discussion 129-30. PubMed ID: 1648816
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
    Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
    [No Abstract]   [Full Text] [Related]  

  • 28. Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis.
    Leong RW; Smith DW; Garas G; Beaman JM; Mitchell AW; Heath DI; House AK; Jeffrey GP
    Intern Med J; 2004 Jul; 34(7):410-5. PubMed ID: 15271175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
    Morgan JD; Horsburgh T; Simpson A; Donnelly PK; Veitch PS; Bell PR
    Transplant Proc; 1992 Dec; 24(6):2634-5. PubMed ID: 1334589
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 31. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects.
    Gadano A; Hadengue A; Widmann JJ; Vachiery F; Moreau R; Yang S; Soupison T; Sogni P; Degott C; Durand F
    Hepatology; 1995 Aug; 22(2):458-65. PubMed ID: 7635413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
    Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
    Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
    Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
    Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
    Hartmann A; Sagedal S; Hjelmesaeth J
    Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.
    Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD; O'Rourke E
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):23-7. PubMed ID: 7940972
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
    Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
    Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
    Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.